Norethindrone And Ethinyl Estradiol And Ferrous Fumarate Kit
Product Images NDC 79929-005

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol And Ferrous Fumarate (NDC 79929-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister11 (Blister11)

Norethindrone and ethinyl estradiol and ferrous fumarate tablet kit label from Naari Pte Limited. The label details a 28-day regimen with dosage strength of 0.4 mg/0.035 mg, arranged in a calendar format with circles for each day of the week and week numbers for dosing. It includes storage instructions and caution to keep out of reach of children.*

FDA Label Image

Figure-01 (Figure 01)

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use,' displaying effect estimates (odds ratio/relative risk) with confidence intervals for various studies from 2002 to 2017. The studies assess breast cancer risk associations with ever or current use of combined oral contraceptives, representing data points aligned around an effect estimate of 1.*

FDA Label Image

Figure-02 (Figure 02)

An illustrated diagram showing contraceptive effectiveness categories based on pregnancy rates per 100 women per year. The chart categorizes methods into four groups: fewer than 1 pregnancy including implants, injections, intrauterine devices, and sterilization; 10 to 20 pregnancies including birth control pills, skin patch, and vaginal ring with hormones; a moderate number including condoms and diaphragm; and more pregnancies including no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Pack (Pack)

The image shows a label for Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets, USP, chewable and ferrous fumarate tablets kit. It is a 28-day regimen packaging with daily circular dosing indicators arranged by week and day of the week, labeled from Sunday to Saturday. The label includes storage instructions, a note that the product is not USP for dissolution and assay, and states it is made by Naari Pte Ltd in India.*

FDA Label Image

Pillpack (Pillpack)

An instructional line drawing showing a hand holding a blister pack of pills, with two arrows pointing at the pack indicating where to press to push out a tablet.*

FDA Label Image

Structure (Structure)

Chemical structure diagrams of norethindrone and ethinyl estradiol, the active ingredients in the norethindrone and ethinyl estradiol and ferrous fumarate tablet kit by Naari Pte Limited (NDC 79929-005). Each structure shows specific molecular configurations and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.